321 related articles for article (PubMed ID: 31145701)
21. Targeted molecular profiling reveals genetic heterogeneity of poromas and porocarcinomas.
Bosic M; Kirchner M; Brasanac D; Leichsenring J; Lier A; Volckmar AL; Oliveira C; Buchhalter I; Stögbauer F; Zivkovic-Perisic S; Goeppert B; Schirmacher P; Penzel R; Endris V; Stenzinger A
Pathology; 2018 Apr; 50(3):327-332. PubMed ID: 29269125
[TBL] [Abstract][Full Text] [Related]
22. Recurrent YAP1 and MAML2 Gene Rearrangements in Retiform and Composite Hemangioendothelioma.
Antonescu CR; Dickson BC; Sung YS; Zhang L; Suurmeijer AJH; Stenzinger A; Mechtersheimer G; Fletcher CDM
Am J Surg Pathol; 2020 Dec; 44(12):1677-1684. PubMed ID: 32991341
[TBL] [Abstract][Full Text] [Related]
23. Hippo pathway effectors YAP1/TAZ induce an EWS-FLI1-opposing gene signature and associate with disease progression in Ewing sarcoma.
Rodríguez-Núñez P; Romero-Pérez L; Amaral AT; Puerto-Camacho P; Jordán C; Marcilla D; Grünewald TG; Alonso J; de Alava E; Díaz-Martín J
J Pathol; 2020 Apr; 250(4):374-386. PubMed ID: 31880317
[TBL] [Abstract][Full Text] [Related]
24. Porocarcinomas with PAK1/2/3 fusions: a series of 12 cases.
Kervarrec T; Westphal D; Pissaloux D; Legrand M; Tirode F; Neuhart A; Drouot F; Becker JC; Macagno N; Seris A; Jouary T; Beltzung F; Jullie ML; Harms PW; Cribier B; Mourah S; Jouenne F; Fromont G; Louveau B; Mancini M; Kazakov DV; de la Fouchardière A; Battistella M
Histopathology; 2024 May; ():. PubMed ID: 38785043
[TBL] [Abstract][Full Text] [Related]
25. Metaplastic thymoma: a distinctive thymic neoplasm characterized by YAP1-MAML2 gene fusions.
Vivero M; Davineni P; Nardi V; Chan JKC; Sholl LM
Mod Pathol; 2020 Apr; 33(4):560-565. PubMed ID: 31641231
[TBL] [Abstract][Full Text] [Related]
26. Comparison of Immunohistochemical Expression of Cytokeratin 19, c-KIT, BerEP4, GATA3, and NUTM1 Between Porocarcinoma and Squamous Cell Carcinoma.
Goto K; Ishikawa M; Hamada K; Muramatsu K; Naka M; Honma K; Sugino T
Am J Dermatopathol; 2021 Nov; 43(11):781-787. PubMed ID: 33767067
[TBL] [Abstract][Full Text] [Related]
27. Poroma: a review of eccrine, apocrine, and malignant forms.
Sawaya JL; Khachemoune A
Int J Dermatol; 2014 Sep; 53(9):1053-61. PubMed ID: 24697501
[TBL] [Abstract][Full Text] [Related]
28. YAP1 and its fusion proteins in cancer initiation, progression and therapeutic resistance.
Szulzewsky F; Holland EC; Vasioukhin V
Dev Biol; 2021 Jul; 475():205-221. PubMed ID: 33428889
[TBL] [Abstract][Full Text] [Related]
29. Molecular characterization of epithelioid haemangioendotheliomas identifies novel WWTR1-CAMTA1 fusion variants.
Patel NR; Salim AA; Sayeed H; Sarabia SF; Hollingsworth F; Warren M; Jakacky J; Tanas M; Oliveira AM; Rubin BP; Lazar AJ; López-Terrada D; Wang WL
Histopathology; 2015 Nov; 67(5):699-708. PubMed ID: 25817592
[TBL] [Abstract][Full Text] [Related]
30. Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling.
Ota M; Sasaki H
Development; 2008 Dec; 135(24):4059-69. PubMed ID: 19004856
[TBL] [Abstract][Full Text] [Related]
31. YAP1/TAZ-TEAD transcriptional networks maintain skin homeostasis by regulating cell proliferation and limiting KLF4 activity.
Yuan Y; Park J; Feng A; Awasthi P; Wang Z; Chen Q; Iglesias-Bartolome R
Nat Commun; 2020 Mar; 11(1):1472. PubMed ID: 32193376
[TBL] [Abstract][Full Text] [Related]
32. TEAD Inhibition Overcomes YAP1/TAZ-Driven Primary and Acquired Resistance to KRASG12C Inhibitors.
Edwards AC; Stalnecker CA; Jean Morales A; Taylor KE; Klomp JE; Klomp JA; Waters AM; Sudhakar N; Hallin J; Tang TT; Olson P; Post L; Christensen JG; Cox AD; Der CJ
Cancer Res; 2023 Dec; 83(24):4112-4129. PubMed ID: 37934103
[TBL] [Abstract][Full Text] [Related]
33. An Unusual Case of a Scrotal Porocarcinoma and Review of the Literature.
Hartsough EM; Moran J; Devins K; Wszolek M; Cornejo KM
Am J Dermatopathol; 2023 Jan; 45(1):51-55. PubMed ID: 36484607
[TBL] [Abstract][Full Text] [Related]
34. NUT carcinoma of the parotid gland: report of two cases, one with a rare ZNF532-NUTM1 fusion.
Chen M; Zhao S; Liang Z; Wang W; Zhou P; Jiang L
Virchows Arch; 2022 Apr; 480(4):887-897. PubMed ID: 35064291
[TBL] [Abstract][Full Text] [Related]
35. Loss of
Goto H; Nishio M; To Y; Oishi T; Miyachi Y; Maehama T; Nishina H; Akiyama H; Mak TW; Makii Y; Saito T; Yasoda A; Tsumaki N; Suzuki A
Development; 2018 Mar; 145(6):. PubMed ID: 29511023
[TBL] [Abstract][Full Text] [Related]
36. Hippo-YAP1 signaling pathway and severe preeclampsia (sPE) in the Chinese population.
Liu R; Wei C; Ma Q; Wang W
Pregnancy Hypertens; 2020 Jan; 19():1-10. PubMed ID: 31841877
[TBL] [Abstract][Full Text] [Related]
37. Discovery of recurrent structural variants in nasopharyngeal carcinoma.
Valouev A; Weng Z; Sweeney RT; Varma S; Le QT; Kong C; Sidow A; West RB
Genome Res; 2014 Feb; 24(2):300-9. PubMed ID: 24214394
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of the Hippo Effectors YAP1/TAZ in Tumors of Soft Tissue and Bone.
Isfort I; Elges S; Cyra M; Berthold R; Renner M; Mechtersheimer G; Åman P; Larsson O; Ratner N; Hafner S; Simmet T; Schliemann C; Rossig C; Dirksen U; Grünewald I; Wardelmann E; Huss S; Hartmann W; Trautmann M
Sci Rep; 2019 Dec; 9(1):19704. PubMed ID: 31873172
[TBL] [Abstract][Full Text] [Related]
39. Atypical Intraparenchymal Meningioma with YAP1-MAML2 Fusion in a Young Adult Male: A Case Report and Mini Literature Review.
Nobee A; Xu M; Seth A; Rong Y
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628996
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemistry of eccrine poroma and porocarcinoma--more than acrosyringeal tumors?
Wollina U; Castelli E; Rülke D
Recent Results Cancer Res; 1995; 139():303-16. PubMed ID: 7541147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
